Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacteria cell wall is a thick, multi-layered, mesh-like structure essential for the survival and pathogenicity of Gram-positive bacteria. Its main component is peptidoglycan, a polymer of glycan strands crosslinked by short peptides, which provides mechanical strength and resists high internal osmotic pressure[1][2][4][5][6][7]. Peptidoglycan is much thicker in Gram-positive bacteria (30–100 nm) than in Gram-negative bacteria[5][6][7]. The wall is additionally reinforced by teichoic acids and lipoteichoic acids (anionic glycopolymers) covalently linked to peptidoglycan or membrane lipids, which are involved in ion homeostasis, surface charge, adherence, and interaction with host defenses[1][2][7]. The outer surface also features diverse proteins with roles in adhesion, nutrient acquisition, and immune evasion[1][5]. The cell wall is the molecular target of several major antibiotic classes, notably β-lactams and glycopeptides, which inhibit critical enzymes required for peptidoglycan biosynthesis, leading to cell lysis and death. Due to its essential function and accessibility, the Gram-positive cell wall is a validated and historically successful therapeutic target, but also the foundation of important clinical challenges such as antimicrobial resistance and inflammatory complications during infection and treatment[4][5][6].
- Inhibition of peptidoglycan synthesis (e.g., β-lactams bind transpeptidases / penicillin-binding proteins) - Blocking cell wall crosslinking (e.g., vancomycin binds D-Ala-D-Ala termini of peptidoglycan precursors) - Disruption of cell membrane integrity (some drugs affect membrane but target is wall-associated) - Inhibition of lipid carrier cycling (e.g., bacitracin) - Induction of bacterial cell lysis due to loss of wall integrity
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive bacteria cell wall.